ArchiMed invests in Provepharm Life Solutions

On April 23, 2018, ArchiMed invested in Provepharm Life Solutions, a life science company in France.

Deal at a glance

AnnouncedApril 23, 2018 TypeGrowth Capital TargetProvepharm Life Solutions Buyer ArchiMed SectorLife Science LocationFrance ValueNot disclosed

Target company

Provepharm Life Solutions

France

Life Sciencesector

2007founded

Activestatus

View the company profile →

Buyer

ArchiMed

Company · 22 deals on record

2nd transaction in life science
5th transaction in France

22deals, all time

8in this sector

2021latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Cell&Co BioServicesSame sector and country · Apr 2022

Questions about this deal

Who acquired Provepharm Life Solutions?ArchiMed invested in Provepharm Life Solutions on April 23, 2018.

What type of deal was it?It was a growth capital in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).